Back to the main directory
Press Release
- SAB Biotherapeutics CEO Eddie Sullivan, PhD, to Present Next Generation Biologics in Immunology at BIO CEO & Investor Conference by GlobeNewsWire
- edgeTI Recognized in Gartner Market Guide for Technologies Supporting a Digital Twin of an Organization by GlobeNewsWire
- Aprea Therapeutics to Participate in 6th Annual DNA Damage and Response (DDR) Inhibitors Summit by GlobeNewsWire
- Otonomo Selected by Iteris to Support Traffic Intelligence Solutions for Public Sector and Commercial Enterprise Markets by GlobeNewsWire
- aTyr Pharma Gains E.U. Patent Covering Use of Efzofitimod with Pirfenidone for Lung Inflammation or Fibrosis by GlobeNewsWire
- FDA Accepts Intercept’s New Drug Application for OCA for the Treatment of Pre-Cirrhotic Liver Fibrosis Due to NASH by GlobeNewsWire
- Outlook Therapeutics® Strengthens Medical Affairs and Commercial Expertise with Appointments of Surendra Sharma, MD, Senior Vice President of Medical Affairs and Glen Olsheim, Executive Director of Commercial Excellence by GlobeNewsWire
- DTE Energy reduces natural gas rate, saving customers money on their heating bills by GlobeNewsWire
- NICE Digitally Transforms Performance and Customer Experience through AI-Driven Employee Engagement Solutions for a leading European BPO by BusinessWire
- Form 8.3 - The Vanguard Group, Inc.: Capital & Counties Properties plc by EQS Group AG
- Wrap Technologies to Present at Lake Street’s Take Aim Conference by GlobeNewsWire
- HOMB’s Disciplined Strategy Leads to a Beat of Management Expectations Despite Continued West Texas Headwinds by GlobeNewsWire
- Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc by EQS Group AG
- CNH Industrial to announce 2022 Fourth Quarter and Full Year financial results on February 2, 2023 by GlobeNewsWire
- Investors House: Kukkula-hankkeen sopimuskokonaisuuden muutoksista neuvottelutulos by GlobeNewsWire
- rms Company Scales Medical Device Production with Addition of 3D Systems’ DMP Flex 350 Dual by GlobeNewsWire
- Salarius Pharmaceuticals to Present SP-3164 Targeted Protein Degrader Preclinical Data at the Inaugural Molecular Glue Drug Development Summit by GlobeNewsWire
- Streamline Health® Expands RevID™ Agreement with Large Provider Network, Achieves Booked SaaS ACV Goal by GlobeNewsWire
- Neuronetics and Greenbrook TMS Announce Six Year Exclusive Partnership by GlobeNewsWire
- SELLAS Life Sciences to Host Key Opinion Leader Webinar on Galinpepimut-S Acute Myeloid Leukemia Program by GlobeNewsWire
- BioCorRx Announces Completion of Treatment Phase of Study Subjects and Preliminary Safety Data from Phase I Clinical Trial of BICX104, an Implantable Naltrexone Pellet for the Treatment of Opioid Use Disorder by GlobeNewsWire
- Huadi International Group Co., Ltd. Has Entered into Strategic Partnership with China Huanqiu Contracting & Engineering Co., Ltd. on Stainless Steel Seamless Pipe Supply by GlobeNewsWire
- Navitas to Acquire Silicon Control IC Company by GlobeNewsWire
- Decklar Resources Inc. Updates Oil Production and Delivery Operations at the Oza Oil Field by GlobeNewsWire
- Form 8.3 - The Vanguard Group, Inc.: Shaftesbury plc by EQS Group AG